Phase II Pethema Trial of Alternating Bortezomib and Dexamethasone As Induction Regimen Before Autologous Stem-Cell Transplantation in Younger Patients With Multiple Myeloma: Efficacy and Clinical Implications of Tumor Response KineticsLaura Rosiñol, Joan Bladé, María‐Victoria Mateos et al.|Journal of Clinical Oncology|2007Cited by 111